Minimally invasive medical devices maker Embolx has partnered with advanced medical equipment distributor Girlow USA to expand access to the former’s medical technologies into South America.
The partnership will involve the use of Girlow’s established distribution channels and network by Embolx to make its medical technologies, including the Sniper Balloon Occlusion Microcatheter, more easily accessible beyond the US and Europe.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It aligns well with Girlow’s mission of providing healthcare professionals with access to advanced medical technologies.
The Sniper microcatheter has been designed to optimise embolic agent delivery to treat different types of cancer and benign prostatic hyperplasia.
The technology will allow healthcare professionals to accurately target cancerous tumours and improve treatment efficacy while reducing complications.
It is claimed to be one of Embolx’s flagship products for embolic treatment procedures.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThrough the partnership, Embolx intends to provide access to its Sniper microcatheter for healthcare workers and institutions across Mexico, South America, Central America and the Caribbean.
Embolx president and CEO Michael Allen said: “We are thrilled to partner with Girlow USA, a highly respected global distributor in the medical field. By combining our expertise, we can make significant strides in improving patient care on a global scale.”
Together, Embolx and Girlow are poised to impact patient care by delivering advanced solutions for healthcare professionals.
